Efficacy of Bupivacain Local Infiltration for the Management of Pain During Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
Pain, Postoperative
Interventions
DRUG

Bupivacain

20 mL of bupivacaine 0.5% will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue.

DRUG

Placebo

20 mL of Normal Saline Solution will be infiltrated. 10 mL will be infiltrated in the inferior border and 10 mL in the superior border of the subcutaneous cellular tissue.

Trial Locations (1)

Unknown

Saint Thomas H, Panama City

All Listed Sponsors
lead

Saint Thomas Hospital, Panama

OTHER